Yuan-Xue Jiang

Suggest Changes
Learn More
Cisplatin and nedaplatin show significant antitumor activity and have been widely used for esophageal squamous cell carcinoma (ESCC). However, it is still unclear whether the efficacy and safety of(More)
  • 1